entertainment -WSS

entertainment

author：comprehensive 2025-08-12 11:30:16 - browse：497

Anthony Fernandez holds a Wegovy injection, the ALP-1 agonist medication he uses to help curb his food cravings – Obesity medication and science coverage for STAT — A person holds a Wegovy injection pen. Kayana Szymczak for STAT

Medicare confirmed this week that it will cover Novo Nordisk’s obesity drug Wegovy if prescribed to prevent heart problems, but policy experts said Medicare patients are still likely to encounter significant barriers getting access to the highly popular and expensive drug.

Medicare previously wasn’t reimbursing for Wegovy, since the federal payer is legally barred from covering weight loss drugs. But the Food and Drug Administration this month approved Wegovy for preventing heart problems in people with obesity and heart disease, leading many to suspect that Medicare would start covering the drug for this usage.

Makers of obesity drugs have been hoping that showing additional benefits beyond weight loss would induce more insurers to cover them. Medicare’s guidance, first reported Thursday, moves in that direction, but experts point out that the private insurers that administer Medicare’s prescription drug benefit — called Part D — can still choose to not include Wegovy on their formularies, especially if they think it would be too costly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： RSV injection headlines need to be accurate for good uptake

entertainment

WSS

Mystery swirls around US soldier who entered North Korea days ago, officials say

Telehealth startups are trying to fill the menopause care vacuum

Judge denies Trump's request for new trial in E. Jean Carroll case

Hormonal contraceptives don’t actually treat endometriosis

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Nobel honors Karikó and Weissman's enduring partnership

knowledge

entertainment

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

What will Novo Nordisk's VC do with its influx of cash?

Peter Hotez and the public health issue of online harassment

Health insurers' Q3 question: how much care are people getting?

The cancer drug shortage isn’t new — and neither are the solutions

Delta passengers in Vegas fall sick while waiting on flight in triple

Dobbs anniversary: the lost opportunity of abortion as health care

WHO recommends second malaria vaccine

Hepatitis C has a cure — but many Americans still lack access to it

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

focus

Scientists grapple with ethics of stem cell research

2023 Nobel Prize in Medicine goes to Karikó and Weissman

IVG is promising — but it won’t replace IVF quite yet

Telehealth startups are trying to fill the menopause care vacuum

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

The Karikó problem: Lessons for funding basic research

hotspot

entertainment

hotspot

hotspot